Synteract snaps up Oracle software for drug safety monitoring

Seeking improved data efficiency and other benefits, the San Diego-based CRO Synteract has adopted two Oracle Argus 7.0 modules for its pharmacovigilance platform. Oracle Argus Safety and Oracle Argus Interchange were added to enhance Synteract's offerings to biopharma companies in early-stage trials through postmarket studies. Also, Synteract is offering Oracle Argus Safety as a hosted application for its biopharma customers. Release

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.